Zhang Jiayou, Nian Xuanxuan, Li Xuedan, Huang Shihe, Duan Kai, Li Xinguo, Yang Xiaoming
National Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, China.
Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.
Vaccines (Basel). 2022 Nov 6;10(11):1873. doi: 10.3390/vaccines10111873.
Influenza prevention and control has been one of the biggest challenges encountered in the public health domain. The vaccination against influenza plays a pivotal role in the prevention of influenza, particularly for the elderly and small children. According to the epidemiology of influenza in China, the nation is under a heavy burden of this disease. Therefore, as a contribution to the prevention and control of influenza in China through the provision of relevant information, the present report discusses the production and batch issuance of the influenza vaccine, analysis of the vaccination status and vaccination rate of the influenza vaccine, and the development trend of the influenza vaccine in China.
流感防控一直是公共卫生领域面临的最大挑战之一。流感疫苗接种在预防流感方面发挥着关键作用,尤其是对老年人和儿童。根据中国流感流行病学情况,该国面临着沉重的流感疾病负担。因此,为通过提供相关信息助力中国的流感防控工作,本报告讨论了流感疫苗的生产和批量发放情况、流感疫苗接种状况及接种率分析,以及中国流感疫苗的发展趋势。